Global drug pricing isn’t just a policy issue—it’s a business-critical variable that affects every player in the pharmaceutical value chain. FromRead More

Biosimilars are near-identical versions of approved biologics, offering similar safety, efficacy, and quality—but at a lower cost. Unlike generics, biosimilars are made from living cells and require complex development and regulatory approval.Read More

The pharmaceutical industry plays a critical role in advancing global health, enabling innovation in drug development, and ensuring access to life-saving treatments across populations.Read More

Ever had a breakthrough idea—only to be stalled by a compound that doesn’t exist yet?Read More

The global active pharmaceutical ingredients industry is estimated to be worth $232.13 billion in 2025. By 2030, this figure is expected to reach $328.94 billion at a CAGR of 7.22%.Read More

A little history teaches us that the pharmaceutical industry has always been in a state of evolution due to rapid changes in technology, health consumer demands, and immediate needs in global health matters.Read More

The role of Indian API suppliers will also be highlighted in the evolution of global healthcare.Read More

Study the essential position of regulatory procedures for drug permission authorization systems.Read More

The pharma environment is seeing a major shift with the introduction of biologics. These complicated, large-molecule medicines are slowly becoming center stage alongside classical small molecules.Read More

Getting new drugs approved is not easy. The medical field moves really fast, and there are many steps. One big part of this is scientific regulatory writing.Read More